Skip to main content

Table 2 Baseline characteristics of the cohort population with IFG and non-IFG

From: Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study

Variable

IFG (N =442)

Non-IFG(N =4,484)

P-value

Age

53.37±14.26

43.99±14.59

<0.0001

Sex

  

<0.0001

Male

286

2,348

 

Female

156

2,136

 

Height

163.70±8.39

163.80±8.21

0.7064

Weight

66.02±11.24

61.89±11.15

<0.0001

BMI

24.54±3.06

22.95±2.99

<0.0001

WC

83.29±8.74

78.70±9.07

<0.0001

SBP

131.30±19.78

120.50±17.21

<0.0001

DBP

79.00±11.75

73.84±10.97

<0.0001

TC

5.02±0.97

4.75±0.90

<0.0001

TG

1.88±1.58

1.38±0.96

<0.0001

HDL-C

1.39±0.37

1.46±0.35

<0.0001

LDL-C

3.02±0.82

2.84±0.80

<0.0001

Blood urea

5.37±1.33

5.03±1.33

<0.0001

SCr

73.87±14.99

70.29±16.27

<0.0001

SUA

352.90±80.42

327.60±86.09

<0.0001

  1. Abbr: IFG Impaired fasting glucose, BMI Body mass index, WC Waist circumference, SBP Systolic Blood pressure, DBP Diastolic Blood pressure, TC Total cholesterol, TG Triglycerides, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, SCr Serum creatinine, SUA Serum uric acid